论文部分内容阅读
目的:探讨治疗小儿支气管肺炎时,沐舒坦作为辅助治疗,改善疗效,提高治愈率。方法:我院2012~2014年期间确诊为小儿支气管肺炎的住院患儿,年龄2-6岁随机选取86例,性别不限,临床表现为发热3-5天,咳嗽有痰,伴或不伴有喘息,肺部听诊可闻及干湿性罗音,胸片表现为小叶性肺炎,随机分为观察组(静脉用沐舒坦)40例及对照组(未静脉用沐舒坦)46例。在相同治疗的基础上,对照组采用抗感染治疗的同时配合雾化吸入糜蛋白酶治疗,观察组在对照组的基础上加用静脉滴注沐舒坦,观察两组患儿治疗后体温正常、气促喘息缓解、肺部湿罗音消退及咳嗽消退时间。结果:静脉滴注沐舒坦治疗小儿支气管肺炎后,较对照组临床表现在24h内就有显著改善,且湿罗音消退快,咳嗽缓解快。结论:静脉滴注沐舒坦治疗小儿支气管肺炎疗效肯定,经济安全,值得推广。
Objective: To investigate the treatment of bronchial pneumonia in children, mucosolvan as adjuvant therapy to improve the curative effect and improve the cure rate. Methods: Hospitalized children with bronchial pneumonia were diagnosed as children with bronchial pneumonia during 2012 ~ 2014 in our hospital. There were 86 cases randomly selected from 2-6 years old. There were no gender, clinical manifestations were fever 3-5 days, cough with sputum, with or without A wheezing, lung auscultation can be heard and wet and dry rales, chest X-ray showed lobular pneumonia, were randomly divided into observation group (intravenous mucosolvan) 40 cases and control group (46 cases without intravenous mucosolvan). On the basis of the same treatment, the control group was treated with anti-infection treatment combined with inhalation of chymotrypsin, the observation group was treated with intravenous infusion of mucosolvan on the basis of the control group, and the normal temperature and gas Promote wheezing relief, lung wet rales and cough subsided time. Results: After intravenous drip of mucosolvan was used to treat children with bronchopneumonia, the clinical manifestations of the patients were better than that of the control group within 24 h, and the wet rales subsided quickly and the cough relieved quickly. Conclusion: The curative effect of infusing mucosolvan on children with bronchopneumonia is affirmed, its economy is safe and it is worth popularizing.